Articles from Addgene, Inc

Marked by decades of scientific partnership, Addgene’s evolution from a pioneering plasmid repository to a trusted resource spanning all stages of research drives refreshed brand

Strategic partnership to ensure delivery of scalable, cost-effective, and reliable plasmid sequencing as Addgene’s repository expands

WATERTOWN, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Addgene, an organization committed to accelerating discovery and innovation by providing a vast catalog of expertly curated and quality-controlled research tools developed by researchers, today announced the appointment of Greg Crescenzi as Vice President of Global Commercial Strategy and Partnerships. With his leadership in commercializing industry-first products and technologies, Crescenzi will drive the organization’s business development efforts while executing a disciplined, mission-aligned commercial strategy across global customer segments. For over twenty years, Addgene has promoted scientific sharing by building a repository where scientists can deposit validated, high-quality research materials, with more than 170,000 plasmids, viral vectors, and antibodies now available to researchers around the world.

Promega Plasmid Collection, available through Addgene, equips industry and academic researchers with powerful bioluminescent assays that provide deeper insights into endogenous cellular biology

Strategic appointments advance Addgene’s growth and market expansion strategy